IQVIA is trading at $271.54, up 4.15% before the October 2, 2026 open, with no clear immediate catalyst identified. - No clearly reported overnight company-specific announcement explaining the move surfaced. The latest company news was its September 23 announcement that it completed a $2 billion senior-notes offering, which predates the rise. - Healthcare sentiment is negative amid insurer-policy concerns, while major U.S. index futures are higher; neither broader signal clearly explains IQVIA’s sharp gain.